e-Drug3D 630 |
cas 19767-45-4 |
CLASS VARIOUS |
ROUTE (list) INJECTION INTRAVENOUS ORAL |
NATURAL MOLECULE (link) | PK parameters F 58 PERCENT |
Target TARGET METABOLITES ACROLEIN AND 4-HYDROXY-IFOSFAMIDE PDB Ligand code = COM (link to the list of PDB complexes) Download experimental 3D coordinates of COM with added hydrogens |
DrugCentral Unknown |
Download SDF file | Ethanesulfonic acid, 2-mercapto-, sodium salt (1:1) Formula: Calculated chemical properties: MW 142.21 NB_atoms 7 XLogP -0.20 PSA 57.092 NB_HD 1 NB_HA 3 fsp3 1.00 Lipinski(0=no;1=yes) 1 |
FDA NDA 019763 (pdf not found) INN (MESNA) IFEX/MESNEX KIT (BAXTER HLTHCARE) APPROVAL= AP YEAR= 1987 NEWMOLECULARENTITY NDA 019884 (pdf not found) INN (MESNA) MESNEX (BAXTER HLTHCARE) APPROVAL= AP YEAR= 1988 NDA 075764 (pdf not found) INN (MESNA) MESNA (TEVA PHARMS USA) APPROVAL= AP YEAR= 2001 DISCONTINUED NDA 075811 (pdf not found) INN (MESNA) MESNA (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2001 NDA 020855 (pdf not found) INN (MESNA) MESNEX (BAXTER HLTHCARE) APPROVAL= AP YEAR= 2002 NDA 075874 (pdf not found) INN (IFOSFAMIDE ; MESNA) IFOSFAMIDE/MESNA KIT (TEVA PHARMS USA) APPROVAL= AP YEAR= 2002 DISCONTINUED NDA 075739 (pdf not found) INN (MESNA) MESNA (HIKMA) APPROVAL= AP YEAR= 2004 NDA 090913 (pdf not found) INN (MESNA) MESNA (SAGENT PHARMS INC) APPROVAL= AP YEAR= 2010 NDA 076488 (pdf not found) INN (MESNA) MESNA (MYLAN INSTITUTIONAL) APPROVAL= AP YEAR= 2012 DISCONTINUED NDA 203364 (pdf not found) INN (MESNA) MESNA (RISING) APPROVAL= AP YEAR= 2014 DISCONTINUED NDA 206992 (pdf not found) INN (MESNA) MESNA (GLAND) APPROVAL= AP YEAR= 2017 NDA 218871 (pdf not found) INN (MESNA) MESNA (RICONPHARMA LLC) APPROVAL= AP YEAR= 2025 |
Other links: |